Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 6 announcements

Share price
₹704.70
Market cap
₹7,493 Cr
Revenue (annual)
₹927.1 Cr
Net profit (annual)
₹129.1 Cr
P/E (TTM)
55.0×Sector 50.4×
Promoter holding
35.01%-0.35% QoQ
FII holding
8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2Employee Stock Options 2Open Offer 1Annual General Meeting 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

19:39 IST NSE
Financial Results

Bliss GVS Pharma Q1 FY27 Results: Net Profit ₹51.4 Cr, Up 15.8% YoY

Bliss GVS Pharma Ltd reported revenue from operations of ₹285.6 Cr (+37.6% YoY) and net profit of ₹51.4 Cr (+15.8% YoY) for Q1 FY27.

Key figure
Net profit ₹51.4 Cr · +15.8% YoY
Open full results → Read the filing ↗
00:49 IST BSE
Financial Results

Bliss GVS Pharma Q4 FY26 Results: Net Profit ₹37 Cr, Up 121.6% YoY

Bliss GVS Pharma Ltd reported revenue from operations of ₹257 Cr (+29.8% YoY) and net profit of ₹37 Cr (+121.6% YoY) for Q4 FY26.

Key figure
Net profit ₹37 Cr · +121.6% YoY
Open full results → Read the filing ↗